Researchers have developed HierDTA, a novel framework for predicting drug-target affinity (DTA) that enhances accuracy by integrating hierarchical structure-aware representations of both drugs and proteins. The model represents drugs as heterogeneous graphs and proteins via residue interaction graphs, using cross-attention to model their specific relationships. HierDTA demonstrates superior performance on the DAVIS and KIBA datasets, showing significant improvements in generalization, particularly in cold-start scenarios for unseen proteins. AI
IMPACT This model could accelerate drug discovery by improving the accuracy and efficiency of identifying potential drug-target interactions.
RANK_REASON The cluster contains an academic paper detailing a new AI model and its performance on scientific benchmarks. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →